Machine Learning Prediction Models for Chronic Kidney Disease Using National Health Insurance Claim Data in Taiwan

Surya Krishnamurthy1, Kapeleshh Ks2, Erik Dovgan3

  • 1School of Information Technology and Engineering, Vellore Institute of Technology (VIT), Vellore 632014, India.

Insights

Machine learning accurately predicts chronic kidney disease (CKD) onset up to 12 months in advance using patient data. This tool aids early detection and resource allocation for managing CKD prevalence.

Area of Science:

  • Nephrology
  • Medical Informatics
  • Artificial Intelligence

Background:

  • Chronic kidney disease (CKD) poses a significant global health burden due to rising prevalence, high progression rates to end-stage renal disease, and associated mortality.
  • Effective prediction models are crucial for proactive healthcare management and resource allocation.

Purpose of the Study:

  • To develop and validate a machine learning model for forecasting CKD onset 6-12 months prior.
  • To utilize comorbidity and medication data from Taiwan's National Health Insurance Research Database for predictive modeling.

Main Methods:

  • Propensity score matching was used to select 18,000 CKD patients and 72,000 controls from a large database.
  • Convolutional Neural Networks (CNN) and tree-based models were trained using demographic, comorbidity, and medication data over a two-year period.

Main Results:

  • The CNN model achieved high predictive accuracy, with an AUROC of 0.957 for 6-month and 0.954 for 12-month predictions.
  • Key predictors identified included diabetes mellitus, gout, age, and specific medications like sulfonamides and angiotensins.

Conclusions:

  • The developed machine learning model shows significant potential for predicting CKD occurrence.
  • This tool can support policymakers in anticipating CKD trends, enabling early detection, risk monitoring, and optimized resource allocation.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
305
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
163
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
115
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
44
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
230
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
108